The Protective Effect of Adalimumab on Renal Injury in a Model of Abdominal Aorta Cross-Clamping


Cure M. C. , Cure E., Kalkan Y., Tumkaya L. , Aydin I. , Kirbas A., ...More

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, vol.25, no.2, pp.219-226, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 25 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.17219/acem/33250
  • Title of Journal : ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
  • Page Numbers: pp.219-226

Abstract

Background. Adalimumab (ADA) is a potent inhibitor of tumor necrosis factor (TNF-alpha). ADA treatment suppresses proinflammatory cytokines, leading to a decrease or inhibition of the inflammatory process.